{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:52:03Z","timestamp":1785372723010,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Older adults with hematologic malignancies (HM) have unique challenges due to age and fitness. The primary aim of this pilot study was to benchmark the ability of multiple biomarkers of aging (p16, epigenetic clocks, T cell gene expression profiles, and T cell receptor excision circles (TREC) to identify frailty as measured by a clinical impairment index (I<jats:sup>2<\/jats:sup>) in patients with HM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>70 patients newly diagnosed with HM had peripheral blood T lymphocytes (PBTL) analyzed for p16<jats:sup>INK4a<\/jats:sup> expression using the OSU_Senescence Nanostring CodeSet. PBTL epigenetic age was measured using 7 epigenetic clocks, and TREC were quantified by qRT-PCR. A composite clinical impairment index (I<jats:sup>2<\/jats:sup>) was generated by combining values from 11 geriatric metrics (Independent Activities of Daily Living (iADL), physical health score, Short Physical Performance Battery (SPPB), Body Mass Index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, self-reported KPS, Blessed Orientation Memory Concentration (BOMC), polypharmacy, Mental Health Inventory (MHI)-17, Medical Outcomes Study (MOS) subscales). Clinical frailty was defined as a score of 7 or greater on the I<jats:sup>2<\/jats:sup>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Age-adjusted p16<jats:sup>INK4a<\/jats:sup> was similar in newly diagnosed patients and healthy controls (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.1). PBTL p16<jats:sup>INK4a<\/jats:sup> levels correlated positively with the Hannum [r\u2009=\u20090.35, 95% CI (0.09\u20130.75); p adj.\u2009=\u20090.04] and PhenoAge [r\u2009=\u20090.37, 95% CI (0.11\u20130.59); p adj.\u2009=\u20090.04] epigenetic clocks. The discrimination ability of the I<jats:sup>2<\/jats:sup> model was calculated using the area under the receiver operating characteristic curve (AUC). After adjusting for chronologic age and disease group, baseline p16<jats:sup>INK4a<\/jats:sup> [AUC\u2009=\u20090.76, 95% CI (0.56\u20130.98); <jats:italic>p<\/jats:italic>\u2009=\u20090.01], Hannum [AUC\u2009=\u20090.70, 95% CI (0.54\u20130.85); <jats:italic>p<\/jats:italic>\u2009=\u20090.01], PhenoAge [AUC\u2009=\u20090.71, 95% CI (0.55\u20130.86); <jats:italic>p<\/jats:italic>\u2009=\u20090.01], and DunedinPACE [AUC\u2009=\u20090.73, 95% CI (0.57\u20130.88); <jats:italic>p<\/jats:italic>\u2009=\u2009\u2009&lt;\u20090.01] measures showed the greatest potential to identify clinical frailty using the I<jats:sup>2<\/jats:sup>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our pilot data suggest that multiple blood-based aging biomarkers have potential to identify frailty in older adults with HM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Implications for Cancer Survivors<\/jats:title>\n                <jats:p>We developed the I<jats:sup>2<\/jats:sup> index to quantify impairments across geriatric domains and discovered that PBTL p16, Hannum, PhenoAge, and DunedinPACE are promising indicators of frailty in HM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11764-024-01591-6","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T14:01:16Z","timestamp":1714312876000},"page":"1168-1178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy"],"prefix":"10.1007","volume":"18","author":[{"given":"Ashley E.","family":"Rosko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed I.","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Woyach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nowshin","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Lepola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Presley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin E.","family":"Burd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,28]]},"reference":[{"issue":"10206","key":"1591_CR1","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(19)31786-6.","journal-title":"Lancet"},{"issue":"26","key":"1591_CR2","doi-asserted-by":"publisher","first-page":"4293-+","DOI":"10.1200\/Jco.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale W, Klepin HD, Williams GR, Alibhai SMH, Bergerot C, Brintzenhofeszoc K, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol. 2023;41(26):4293-+. https:\/\/doi.org\/10.1200\/Jco.23.00933.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1591_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1200\/OP.23.00263","volume":"19","author":"GR Williams","year":"2023","unstructured":"Williams GR, Hopkins JO, Klepin HD, Lowenstein LM, Mackenzie A, Mohile SG, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline questions and answers. JCO Oncol Pract. 2023;19(9):718\u201323. https:\/\/doi.org\/10.1200\/OP.23.00263.","journal-title":"JCO Oncol Pract"},{"issue":"10314","key":"1591_CR4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu HW, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398(10314):1894\u2013904. https:\/\/doi.org\/10.1016\/S0140-6736(21)01789-X.","journal-title":"Lancet"},{"issue":"11","key":"1591_CR5","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, Sun CL, Kim H, Soto-Perez-de-Celis E, Chung V, Koczywas M, et al. Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. Jama Oncol. 2021;7(11):e214158. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4158.","journal-title":"Jama Oncol"},{"issue":"21","key":"1591_CR6","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1182\/blood-2012-12-471680","volume":"121","author":"HD Klepin","year":"2013","unstructured":"Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 2013;121(21):4287\u201394. https:\/\/doi.org\/10.1182\/blood-2012-12-471680.","journal-title":"Blood"},{"issue":"4","key":"1591_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/bjc.2017.202","volume":"117","author":"L Kirkhus","year":"2017","unstructured":"Kirkhus L, Saltyte Benth J, Rostoft S, Gronberg BH, Hjermstad MJ, Selbaek G, et al. Geriatric assessment is superior to oncologists\u2019 clinical judgement in identifying frailty. Br J Cancer. 2017;117(4):470\u20137. https:\/\/doi.org\/10.1038\/bjc.2017.202.","journal-title":"Br J Cancer"},{"issue":"25","key":"1591_CR8","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/Jco.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457\u201365. https:\/\/doi.org\/10.1200\/Jco.2011.34.7625.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1591_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clim.2007.12.002","volume":"127","author":"M Czesnikiewicz-Guzik","year":"2008","unstructured":"Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, et al. T cell subset-specific susceptibility to aging. Clin Immunol. 2008;127(1):107\u201318. https:\/\/doi.org\/10.1016\/j.clim.2007.12.002.","journal-title":"Clin Immunol"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.0105-2896.2005.00259.x","volume":"205","author":"RB Effros","year":"2005","unstructured":"Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8(+) T-cell replicative senescence in human aging. Immunol Rev. 2005;205:147\u201357. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00259.x.","journal-title":"Immunol Rev"},{"issue":"20","key":"1591_CR11","doi-asserted-by":"publisher","first-page":"28783","DOI":"10.18632\/oncotarget.8939","volume":"7","author":"YX Lu","year":"2016","unstructured":"Lu YX, Tan CTY, Nyunt MSZ, Mok EWH, Camous X, Kared H, et al. Inflammatory and immune markers associated with physical frailty syndrome: findings from Singapore longitudinal aging studies. Oncotarget. 2016;7(20):28783\u201395. https:\/\/doi.org\/10.18632\/oncotarget.8939.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"1591_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0047-6374(00)00094-4","volume":"115","author":"JL Fahey","year":"2000","unstructured":"Fahey JL, Schnelle JF, Boscardin J, Thomas JK, Gorre ME, Aziz N, et al. Distinct categories of immunologic changes in frail elderly. Mech Ageing Dev. 2000;115(1\u20132):1\u201320. https:\/\/doi.org\/10.1016\/S0047-6374(00)00094-4.","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"1591_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1474-9726.2009.00489.x","volume":"8","author":"Y Liu","year":"2009","unstructured":"Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8(4):439\u201348. https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00489.x.","journal-title":"Aging Cell"},{"issue":"2","key":"1591_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/1541-7786.Mcr-13-0350","volume":"12","author":"KM LaPak","year":"2014","unstructured":"LaPak KM, Burd CE. The molecular balancing act of p16(INK4a) in cancer and aging. Mol Cancer Res. 2014;12(2):167\u201383. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-13-0350.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"1591_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/bmt.2015.143","volume":"50","author":"A Rosko","year":"2015","unstructured":"Rosko A, Hofmeister C, Benson D, Efebera Y, Huang Y, Gillahan J, et al. Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transplant. 2015;50(10):1379\u201381. https:\/\/doi.org\/10.1038\/bmt.2015.143.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1591_CR16","doi-asserted-by":"publisher","first-page":"dju057","DOI":"10.1093\/jnci\/dju057","volume":"106","author":"HK Sanoff","year":"2014","unstructured":"Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, et al. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. Jnci-J Natl Cancer I. 2014;106(4):dju057. https:\/\/doi.org\/10.1093\/jnci\/dju057.","journal-title":"Jnci-J Natl Cancer I"},{"key":"1591_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ebiom.2016.08.029","volume":"11","author":"WA Wood","year":"2016","unstructured":"Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, et al. Chemotherapy and stem cell transplantation increase p16(INK4a) expression, a biomarker of T-cell aging. EBioMedicine. 2016;11:227\u201338. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.029.","journal-title":"EBioMedicine"},{"issue":"6712","key":"1591_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/25374","volume":"396","author":"DC Douek","year":"1998","unstructured":"Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396(6712):690\u20135. https:\/\/doi.org\/10.1038\/25374.","journal-title":"Nature"},{"issue":"1","key":"1591_CR19","doi-asserted-by":"publisher","first-page":"dvad005","DOI":"10.1093\/eep\/dvad005","volume":"9","author":"SH Watkins","year":"2023","unstructured":"Watkins SH, Testa C, Chen JT, De Vivo I, Simpkin AJ, Tilling K, et al. Epigenetic clocks and research implications of the lack of data on whom they have been developed: a review of reported and missing sociodemographic characteristics. Environ Epigenetics. 2023;9(1):dvad005. https:\/\/doi.org\/10.1093\/eep\/dvad005.","journal-title":"Environ Epigenetics"},{"issue":"10","key":"1591_CR20","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115.","journal-title":"Genome Biol"},{"issue":"7","key":"1591_CR21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","volume":"10","author":"S Horvath","year":"2018","unstructured":"Horvath S, Oshima J, Martin GM, Lu AT, Quach A, Cohen H, et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY). 2018;10(7):1758\u201375. https:\/\/doi.org\/10.18632\/aging.101508.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"1591_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573\u201391. https:\/\/doi.org\/10.18632\/aging.101414.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"1591_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019;11(2):303\u201327. https:\/\/doi.org\/10.18632\/aging.101684.","journal-title":"Aging (Albany NY)"},{"key":"1591_CR24","doi-asserted-by":"publisher","unstructured":"Belsky DW, Caspi A, Corcoran DL, Sugden K, Poulton R, Arseneault L, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife. 2022;11. https:\/\/doi.org\/10.7554\/eLife.73420.","DOI":"10.7554\/eLife.73420"},{"issue":"1","key":"1591_CR25","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/s41598-023-29912-2","volume":"13","author":"M Onizuka","year":"2023","unstructured":"Onizuka M, Imanishi T, Harada K, Aoyama Y, Amaki J, Toyosaki M, et al. Donor cord blood aging accelerates in recipients after transplantation. Sci Rep. 2023;13(1):2603. https:\/\/doi.org\/10.1038\/s41598-023-29912-2.","journal-title":"Sci Rep"},{"issue":"2","key":"1591_CR26","doi-asserted-by":"publisher","first-page":"e12897","DOI":"10.1111\/acel.12897","volume":"18","author":"A Soraas","year":"2019","unstructured":"Soraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, et al. Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells. Aging Cell. 2019;18(2):e12897. https:\/\/doi.org\/10.1111\/acel.12897.","journal-title":"Aging Cell"},{"issue":"2","key":"1591_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/10998004221135628","volume":"25","author":"L Mohanraj","year":"2023","unstructured":"Mohanraj L, Wolf H, Silvey S, Liu J, Toor A, Swift-Scanlan T. DNA methylation changes in autologous hematopoietic stem cell transplant patients. Biol Res Nurs. 2023;25(2):310\u201325. https:\/\/doi.org\/10.1177\/10998004221135628.","journal-title":"Biol Res Nurs"},{"issue":"1","key":"1591_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s40001-023-01145-z","volume":"28","author":"KP Loh","year":"2023","unstructured":"Loh KP, Sanapala C, Jensen-Battaglia M, Rana A, Sohn MB, Watson E, et al. Exercise and epigenetic ages in older adults with myeloid malignancies. Eur J Med Res. 2023;28(1):180. https:\/\/doi.org\/10.1186\/s40001-023-01145-z.","journal-title":"Eur J Med Res"},{"issue":"9","key":"1591_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.6004\/jnccn.2020.7686","volume":"19","author":"AE Rosko","year":"2021","unstructured":"Rosko AE, Wall S, Baiocchi R, Benson DM, Brammer JE, Byrd JC, et al. Aging phenotypes and restoring functional deficits in older adults with hematologic malignancy. J Natl Compr Canc Netw. 2021;19(9):1027\u201336. https:\/\/doi.org\/10.6004\/jnccn.2020.7686.","journal-title":"J Natl Compr Canc Netw"},{"issue":"20","key":"1591_CR30","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1200\/Jco.2015.65.4327","volume":"34","author":"A Hurria","year":"2016","unstructured":"Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34(20):2366-U104. https:\/\/doi.org\/10.1200\/Jco.2015.65.4327.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1591_CR31","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/cncr.21422","volume":"104","author":"A Hurria","year":"2005","unstructured":"Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, et al. Developing a cancer-specific geriatric assessment - a feasibility study. Cancer. 2005;104(9):1998\u20132005. https:\/\/doi.org\/10.1002\/cncr.21422.","journal-title":"Cancer"},{"issue":"4","key":"1591_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","volume":"36","author":"GG Fillenbaum","year":"1981","unstructured":"Fillenbaum GG, Smyer MA. The development, validity, and reliability of the oars multidimensional functional assessment questionnaire. J Gerontol. 1981;36(4):428\u201334. https:\/\/doi.org\/10.1093\/geronj\/36.4.428.","journal-title":"J Gerontol"},{"key":"1591_CR33","volume-title":"Measuring functioning and well-being : the medical outcomes study approach","author":"AL Stewart","year":"1992","unstructured":"Stewart AL, Ware JE, Stewart AL, Ware JE. Measuring functioning and well-being\u202f: the medical outcomes study approach. Durham: Duke University Press; 1992."},{"issue":"6","key":"1591_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL. The Mos social support survey. Soc Sci Med. 1991;32(6):705\u201314. https:\/\/doi.org\/10.1016\/0277-9536(91)90150-B.","journal-title":"Soc Sci Med"},{"issue":"6","key":"1591_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1176\/ajp.140.6.734","volume":"140","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiat. 1983;140(6):734\u20139.","journal-title":"Am J Psychiat"},{"issue":"2","key":"1591_CR36","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Guralnik","year":"1994","unstructured":"Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower-extremity function - association with self-reported disability and prediction of mortality and nursing-home admission. J Gerontol. 1994;49(2):M85\u201394. https:\/\/doi.org\/10.1093\/geronj\/49.2.M85.","journal-title":"J Gerontol"},{"issue":"5","key":"1591_CR37","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1200\/JCO.1987.5.5.756","volume":"5","author":"L Levin","year":"1987","unstructured":"Levin L, Hryniuk WM. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol. 1987;5(5):756\u201367. https:\/\/doi.org\/10.1200\/JCO.1987.5.5.756.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1591_CR38","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1200\/Jco.1998.16.9.3137","volume":"16","author":"W Hryniuk","year":"1998","unstructured":"Hryniuk W, Frei E, Wright FA. A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity. J Clin Oncol. 1998;16(9):3137\u201347. https:\/\/doi.org\/10.1200\/Jco.1998.16.9.3137.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1591_CR39","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1093\/gerona\/glaa108","volume":"75","author":"CE Burd","year":"2020","unstructured":"Burd CE, Peng J, Laskowski BF, Hollyfield JL, Zhang S, Fadda P, et al. Association of epigenetic age and p16INK4a with markers of T-Cell composition in a healthy cohort. J Gerontol A Biol Sci Med Sci. 2020;75(12):2299\u2013303. https:\/\/doi.org\/10.1093\/gerona\/glaa108.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1591_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","volume":"49","author":"G Hannum","year":"2013","unstructured":"Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359\u201367. https:\/\/doi.org\/10.1016\/j.molcel.2012.10.016.","journal-title":"Mol Cell"},{"issue":"1","key":"1591_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41514-022-00085-y","volume":"8","author":"LPD Camillo","year":"2022","unstructured":"Camillo LPD, Lapierre LR, Singh R. A pan-tissue DNA-methylation epigenetic clock based on deep learning. Npj Aging. 2022;8(1):4. https:\/\/doi.org\/10.1038\/s41514-022-00085-y.","journal-title":"Npj Aging."},{"issue":"9","key":"1591_CR42","doi-asserted-by":"publisher","first-page":"1129-+","DOI":"10.1038\/s41587-021-01049-5","volume":"39","author":"J Foox","year":"2021","unstructured":"Foox J, Tighe SW, Nicolet CM, Zook JM, Byrska-Bishop M, Clarke WE, et al. Performance assessment of DNA sequencing platforms in the ABRF next-generation sequencing study. Nat Biotechnol. 2021;39(9):1129-+. https:\/\/doi.org\/10.1038\/s41587-021-01049-5.","journal-title":"Nat Biotechnol"},{"key":"1591_CR43","doi-asserted-by":"publisher","unstructured":"Parikh CR, Philbrook HT. Statistical considerations in analysis and interpretation of biomarker studies. In: Biomarkers of Kidney Disease, 2nd Edition; 2017. p. 21\u201332. https:\/\/doi.org\/10.1016\/B978-0-12-803014-1.00002-9.","DOI":"10.1016\/B978-0-12-803014-1.00002-9"},{"issue":"7","key":"1591_CR44","doi-asserted-by":"publisher","first-page":"e1081","DOI":"10.1200\/op.21.00743","volume":"18","author":"A Gajra","year":"2022","unstructured":"Gajra A, Jeune-Smith Y, Fortier S, Feinberg B, Phillips E, Balanean A, et al. The use and knowledge of validated geriatric assessment instruments among US community oncologists. JCO Oncol Pract. 2022;18(7):e1081\u201390. https:\/\/doi.org\/10.1200\/op.21.00743.","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"1591_CR45","doi-asserted-by":"publisher","first-page":"pkaa082","DOI":"10.1093\/jncics\/pkaa082","volume":"4","author":"SS Shachar","year":"2020","unstructured":"Shachar SS, Deal AM, Reeder-Hayes KE, Nyrop KA, Mitin N, Anders CK, et al. Effects of breast cancer adjuvant chemotherapy regimens on expression of the aging biomarker, p16(INK4a). Jnci Cancer Spect. 2020;4(6):pkaa082. https:\/\/doi.org\/10.1093\/jncics\/pkaa082.","journal-title":"Jnci Cancer Spect"},{"issue":"6","key":"1591_CR46","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3324\/haematol.2012.077537","volume":"98","author":"D Brusa","year":"2013","unstructured":"Brusa D, Serra S, Coscia M, Rossi D, D\u2019Arena G, Laurenti L, et al. The PD-1\/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica. 2013;98(6):953\u201363. https:\/\/doi.org\/10.3324\/haematol.2012.077537.","journal-title":"Haematologica"},{"key":"1591_CR47","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.3389\/fimmu.2018.02809","volume":"9","author":"L Agresta","year":"2018","unstructured":"Agresta L, Hoebe KHN, Janssen EM. The emerging role of CD244 signaling in immune cells of the tumor microenvironment. Front Immunol. 2018;9:2809. https:\/\/doi.org\/10.3389\/fimmu.2018.02809.","journal-title":"Front Immunol"},{"issue":"2","key":"1591_CR48","doi-asserted-by":"publisher","first-page":"IA015","DOI":"10.1158\/1538-7445.Agca22-Ia015","volume":"83","author":"CE Burd","year":"2023","unstructured":"Burd CE. The tick-tock of epigenetic clocks in patients with cancer. Cancer Res. 2023;83(2):IA015\u2013IA015. https:\/\/doi.org\/10.1158\/1538-7445.Agca22-Ia015.","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-024-01591-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-024-01591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:29:12Z","timestamp":1723627752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-024-01591-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s11764-024-01591-6","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,28]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by The Ohio State University's Institutional Review Board and patients were consented for participation in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A. M. has served on the scientific advisory board of Abbvie, Genentech, BMS, Rigel Pharmaceuticals, Ryvu Therapeutics and has served on the data and safety monitoring board of Jazz Pharmaceuticals, Daiichi Saynko, and Foghorn Therapeutics. She also serves as a Senior Medical Director for the Leukemia and Lymphoma Society\u2019s Beat AML study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}